The practice at ArentFox Schiff is noted by clients for its ‘leading deep tech experience’, and has a strong reputation for its capabilities handling complex work spanning patent prosecution, litigation, and transactional matters. The team is co-led from New York by patent, trademark and copyright specialist Richard LaCava, and from Washington DC by Wilburn Chesser who specializes in tech-related patent work spanning various sectors. Further names to note on the East Coast include New York-based Michael Scarpati and Alexander Spiegler, and Washington DC-based Brian Stevens, who has expertise handling design patent matters. Engineering and life sciences expert Joseph Maraia joined the firm’s Boston office alongside others from Burns & Levinson, LLP in July 2024. Key practitioners on the West Coast include Craig Gelfound, 'a legend of the IP scene’ according to clients, who is noted for his experience in patent prosecution, litigation and transaction-related work. Anna Lloyd left the firm in August 2024.

The team at Fenwick & West LLP is well-placed to assist its portfolio of clients - including renowned, sector-spanning names -  in a wide range of patent matters, regularly advising on the establishment, expansion, and management of patent portfolios, and related strategic counseling. Michael Farn has expertise in patents and emerging tech and co-leads the team alongside Rajiv Patel who advises tech and life sciences companies on their IP strategy; both are based in Silicon Valley. At the same office, key names include Robert Hulse, who has experience building portfolios in technical fields; Antonia Sequeira, who has a life sciences focus; Hayan Yoon, who assists clients with IP risk mitigation, diligence, and the proceedings surrounding litigation; and Daniel Becker, who has strong capabilities in pharmaceuticals and biotech. Daniel Brownstone is a name to note at the firm’s New York office. Carl Morales, formerly of the New York office, left in January 2025.

Finnegan, Henderson, Farabow, Garrett & Dunner LLP‘s team is well-equipped to advise on complex patent work for a diverse roster of clients. Its workload ranges from advising on the establishment and management of global patent portfolios to handling complex litigation. Nishla Keiser and Jeffrey Jacobstein are experienced in handling contentious patent matters and providing strategic counseling relating to life sciences and biotech, in particular. Cory Bell handles post-grant patent management concerning computer and electronic tech. Bell and Jacobstein are both based in Boston. Erika Harmon Arner is a PTAB and related appeals specialist who splits her time between Reston and Washington DC, and is experienced acting for both patent challengers and owners. The three co-head the practice alongside DC’s Anand Sharma. Also at the DC office, Gracie Mills - who was promoted to partner in January 2025 - has expertise in PTAB work, while Adriana Burgy has a specialism assisting with pharma, biotech and chemical industry-related issues. On the West Coast, Arpita Bhattacharyya is a key practitioner.

Knobbe Martens Olson & Bear LLP‘s group is well-regarded for the breadth of its capabilities in complex patent matters, with biotech, life sciences, medical devices, and electrical engineering being key areas of specialism across the group. Irvine-based Salima Merani is well-placed to assist clients with patent prosecution, portfolio management, and transactional due diligence matters. Merani heads up the team alongside Sabing Lee (also based in Irvine), who advises medtech clients on the IP strategy aspects of complex transactions. Merani and Lee also co-chair the firm’s medical device group. Also in Irvine, Harnik Shukla has noteworthy abilities in procuring successfully litigated patents. In Seattle, Melanie Seelig has expertise in patent infringement, validity, and clearance matters. At the San Diego office, Jason Jardine is experienced in advising on the acquisition, protection, and enforcement of IP rights in both domestic and cross-border contexts.

The group at Baker Botts L.L.P. is noted for its capabilities to handle the a host of patent matters, advising its varied client portfolio on complex matters involving licensing, portfolio development, and patent analysis. The team also advises clients on general patent strategy. Christa Brown-Sanford heads up the team from Dallas, drawing on key expertise in tech, particularly in the telecoms and electronics sectors. The other co-heads are Samir Bhavsar, who handles patent mining, preparation, and prosecution at the same office, as well as Jennifer Tempesta and Sandra Lee —both based in New York—noted for their experience in pharmaceutical, chemical, medical device, and consumer products matters. Eliot Williams (Washington DC) and Chad Walters (Dallas) are both standout practitioners with PTAB trial specialisms. Natalie Gonzales left to join Yetter Coleman LLP in May 2024.

Haynes and Boone, L.L.P. is particularly well-versed in patent application work across the tech world, including nanotech, telecoms, and medical devices. The team’s workload encompasses protecting and enforcing design rights; establishing and managing patent portfolios; and advising on tech and IP licensing. It is also equipped to represent well-known clients in proceedings before the USPTO. Andrew Lowes and experienced PTAB attorney David O’Dell are both based in the Plano office. Washington DC-based Jeffrey Wolfson assists a range of clients, from major corporations to start-ups, with the establishment and management of their patent portfolios. The three jointly head up the group. David McCombs is a key name to note in Dallas, while Costa Mesa’s Tom Chen and San Francisco’s Charlene Liu ‘provide exceptional client support’. Noteworthy team changes include Raghav Bajaj's departure in August 2024, and patent counseling and prosecution expert Brian Gustafson joining the San Francisco office from Fish & Richardson P.C. in October 2024.

The team at Kilpatrick Townsend & Stockton routinely assists its clients with the management of patent portfolios and related strategic advice, and is also hugely experienced in high-stakes patent disputes. The team’s post-grant offering is also noteworthy, regularly assisting clients with IPR, PGR, and CBM proceedings—a particular area of focus for Denver-based Justin Krieger. The team is headed up from Atlanta by Jennifer Arkowitz, Michael Turton, and IP litigator Vaibhav Kadaba. Walnut Creek-based Joseph Snyder is well-regarded for his abilities across a range of sectors including life sciences and tech, advising in both domestic and cross-border contexts. Seattle-based Jesse Bennett is experienced in patent preparation, prosecution and counseling. In Winston-Salem, Charles Calkins is noted for his expertise in handling patents in transactional contexts, and Cynthia Rothschild‘s practice includes advising on portfolios.

Morgan, Lewis & Bockius LLP works with a sector-spanning clientele on the broad scope of complex patent cases. Its varied workload includes assisting with the filing and prosecuting of patents before the USPTO, handling proceedings before the PTAB, and advising on PGRs and IPRs. Philadelphia-based Louis Beardell specializes in life sciences, financial services, and tech-related work, and Dion Bregman, who works from the Silicon Valley office, has particular expertise in PTAB trials. Beardell and Bregman co-lead the group. In Boston, Stephen Altieri  specializes in life sciences counseling, procurement, and licensing cases, while Hosang Lee is also a key name to note. San Francisco-based practitioner Christina MacDougall is experienced in advising on global prosecution strategies including portfolio management. Gary Williams and Tae-Woong Koo are further noteworthy practitioners in the Silicon Valley office, while life sciences expert Christopher Betti is a key name in Chicago.

The ‘incredibly talented’ team at East Coast-based IP boutique Wolf, Greenfield & Sacks, P.C. has a strong reputation on account of its life sciences expertise, in particular. Representing clients in complex PGRs and IPRs before the PTAB forms a significant portion of the group’s workload, and it is also well-equipped to advise on due diligence aspects of IP and all aspects of the establishment of patents. Key attorneys in the team include post-grant proceedings specialist Richard Giunta; highly experienced post-grant and PTAB trial specialist Scott McKeown; and Elisabeth Hunt who represents major corporate clients in complex IP matters. Patrick Waller and Heather DiPietrantonio are further key names to note. Hunter Baker‘s areas of sector expertise include biologics, polymers, and pharmaceuticals, while Oona Johnstone and Daniel Young boast a specialty in biotech cases. Robert Walat heads up the offering. All named attorneys are based in Boston.

The Washington DC-based Bookoff McAndrews is headed up by Christopher Agrawal, who steers the team on a wide range of patent matters including portfolio management and prosecution cases. Determining the patentability of applications is an area of specialism of Sangwoo Ahn, while Les Bookoff is highly experienced in strategic patent counseling. Other key figures include Aaron Johnson who is experienced in handling patent prosecution matters with international scope; Kirsten Johnson who specializes in sectors from biochem to tech; and patent strategist Dinesh Melwani. Ankit Aggarwal is experienced in PTAB work while Arash Hamidi advises on post-grant matters and third-party patents. Jameson Ma represents clients in licensing negotiations.

Cooley LLP frequently works with clients on patent portfolio creation and management and related transactions, due diligence, and financings across a range of sectors. The practice is headed up by Boston-based life sciences and health specialist Matthew Pavao, who is experienced in assisting with global patent acquisition. At the same office, Heidi Elracher offers strategic advice on various high-value cases, while Washington DC-based Chris Holly is noted for his expertise in due diligence. On the West Coast, Mika Reiner Mayer‘s workload includes advising life sciences companies and their investors on the due diligence aspects of patent matters, while Madhuri Roy is also a key name to note in Palo Alto. Former team lead Ivor Elfiri left the New York office in August 2024 for an in-house role.

Noted for its ‘deep understanding’ of clients’, DLA Piper LLP (US)‘s sector experience ranges from molecular biology and physics, to electrical engineering and AI. Heading the team are San Diego-based Sean Cunningham, San Francisco-based Gina Durham, and Boston-based Larissa Bifano, who has expertise handling the full scope of patent matters, from advising on diligence and strategic aspects, to prosecuting and litigating. Christopher Eide in Palo Alto is experienced in handling patent prosecution in both domestic and global contexts. Patent protection and handling transactional IP are specialist areas for San Diego-based Lisa Haile, and Peter Yim has notable post-grant proceedings expertise. In San Francisco, Brian Ho is also a key attorney, while in Philadelphia, Joseph Wolfe has a specialty in AI-related cases.

McDermott Will & Emery LLP‘s team is well-placed to assist its sector-spanning portfolio of clients with an array of complex work. Co-practice head William Gaede splits his time between Silicon Valley and San Francisco, while fellow co-head and ‘trusted advisor’ Ahsan Shaikh—based between Silicon Valley and Chicago—is experienced in computer tech-related patent portfolio establishment, management, and related strategizing. Also in Silicon Valley, Judy Mohr is equipped to assist clients with the protection of their patents, develop global IP strategies, and assist in the procurement of foreign patents. On the East Coast, Boston’s Charles Larsen is a key attorney with capabilities covering patent strategy, transactions, and disputes in both domestic and cross-jurisdictional contexts. Edward Gordon left the team in February 2024.

The group at Morrison Foerster advises a varied roster of clients on the management and development of patent portfolios in both domestic and global contexts. Biotech and medical devices are key areas of expertise across the team. The practice is led by Michael Ward, who works from both the Boston and San Francisco offices, and Palo Alto-based Shannon Reaney. Also in Palo Alto, Catherine Polizzi regularly develops IP strategies for a number of health tech clients, while Anita Choi's workload covers the development of patent portfolios for startups in the life sciences, food, and agriculture industries. Washington DC-based Jonathan Bockman is a standout attorney with experience handling disputes before the USPTO.

The practice at Arnold & Porter assists clients with patent strategy, portfolio development and protection, and with the procurement of patents in both domestic and global contexts. The team is also well-versed in contentious proceedings. Chicago-based practice co-head Dina Hayes leads the team alongside San Francisco’s Douglas Winthrop. On the East Coast, Washington DC-based David Marsh handles proceedings before the USPTO, including IPRs and re-examinations. At the same office, Alice Ho is equipped to litigate before the PTAB, particularly for pharmaceutical, life sciences, medical devices, and biotech clients.

Baker McKenzie LLP works with a host of clients—from software and tech, to entertainment—on the full range of patent matters. Its workload includes obtaining the grant of patents to establish a portfolio, providing pre-litigation advice to well-known names, and preparing and prosecuting patent applications in national and international contexts. John Flaim, who handles patent litigation and portfolio management in particular, leads the Dallas-based team. Mackenzie Martin is equipped to litigate in patent infringement cases and proceedings before the USPTO and the ITC. Vas Vedantam is praised for an ‘analytical approach’, while Jessica Greenwald is also noteworthy. Richard Wells left in November 2024.

Headed up from Washington DC by Mark Tidman, the group at BakerHostetler has well-established capabilities advising on life sciences and advanced materials patent matters, as well as broader experience in tech sector-related work. The group’s client list features renowned names including Meta and Amazon. In Philadelphia, Joseph Lucci is a key attorney with expertise across patent prosecution and litigation, portfolio management and due diligence; Steven Samuels has experience in procurement, licensing and litigation; while Stephanie Lodise assists clients in the building of patent portfolios. Felicity Groth acts for domestic and international clients. On the West Coast, Mark Itri is a noteworthy attorney.

The Boston-based group at Choate, Hall & Stewart is noted as ‘experts in this area’, able to advise clients on the broad range of patent cases, from drafting and prosecuting patent applications to assisting with IP-related agreements. Biotech, pharma, and specialty chemical-related patent matters are some of Brenda Herschbach Jarrell‘s focus areas. Charles Lyon has expertise analyzing the risks of IP transactions for clients. Kristen Buteau specializes in patent protection matters involving therapeutics and chemistry-related tech in particular, and Brian Reese is equipped to handle transactional IP issues, due diligence, and portfolio management; the pair co-lead the team.

The Boston-based team at Dechert has notable capabilities advising its clientele on the patent-related aspects that underpin significant financial transactions. Further, it handles strategy, prosecution, and implementation elements of various patents. Andrea Reid and Andrew Wilkins co-head the offering; Reid has expertise in life sciences matters while Wilkins specializes in the management of portfolios relating to large molecules. Chad Davis‘ workload includes handling IP risk assessments, due diligence aspects, and the handling of the prosecution and development of patent portfolios. John Rearick also advises on patent due diligence, particularly in the life sciences space.

Eversheds Sutherland‘s group is well-equipped to handle the remit of patent prosecution matters. In Atlanta, Peter Pappas has capabilities assisting clients with IP protection and transaction-related issues; Kevin King is equipped to handle IP matters in medical devices, pharma, and biochem industry sectors; and William Warren has expertise in IP strategizing, particularly in life sciences contexts. Further names to note in Atlanta include Malvern Griffin whose workload includes managing patent portfolios for large corporations and research institutions, and Umar Bakhsh. King, Pappas, and Warren co-head the practice alongside Austin-based Nash Zogaib. Former co-lead Christopher Bolten left in May 2024.

Goodwin‘s group has a strong reputation for its patent prosecution work in the life sciences and tech sectors in particular. The team is also equipped to assist across pharma, medical devices, and tech among other sectors, advising on patent matters covering clearance, patentability, infringement, and validity, among other areas. The team is helmed by Boston-based Catherine McCarty and James Riley, who works from Silicon Valley. A life sciences expert with a specialism in drug development, Theresa Kavanaugh is a key name in Boston. Carl Morales joined the New York office from Fenwick & West LLP in January 2025.

The ‘powerhouse’ group at Greenberg Traurig LLP is co-headed by New Jersey-based patent prosecution specialist Barry Schindler, who has experience acting before the USPTO; Boston-based Melissa Hunter-Ensor, who provides IP-related assistance to a wide range of companies, from startups to global institutions; and Denver-based Heath Briggs, who represents companies, particularly in the tech sector, in IPR proceedings. Alongside Hunter-Ensor in Boston are Roman Fayerberg, who clients describe as ‘a patent guru’, and the ‘superb’ David Dykeman. Medtech and tech specialist Christopher Bolten joined the team in San Diego in May 2024.

The team at Norton Rose Fulbright US LLP is well-placed to assist its clients with the scope of patent cases, from analyzing the patentability of new tech to drafting and negotiating licensing agreements, managing portfolios, and handling post-grant proceedings and disputes. Austin-based Eagle Robinson heads the team alongside Tim Kenny in Minneapolis; Robinson advises clients on their IP expansion and also has capabilities representing clients in IPR and PGR proceedings. Gina Shishima, who splits her time between Austin and New York, is experienced in handling prosecution, due diligence, litigation, and post-grant matters as well as providing IP-related transactional guidance.

The team at Paul Hastings LLP has noteworthy expertise handling IPRs, CGMs and PGRs across the tech and life sciences sectors, in particular. At the Washington DC office, Naveen Modi has significant experience assisting in post-grant contexts and handling litigation before the US district court, federal appeals court, and the ITC, where they are often supported by Joseph Palys. DC-based Phillip Citroën also draws on key experience in PTAB matters. In New York, Bruce Wexler is an attorney to note, as is Eric Dittmann, whose workload includes bet-the-company IP disputes, enforcement cases, and patent infringement lawsuits. On the West Coast, Palo Alto’s Lisa Nguyen is a standout figure. Modi, Wexler and Dittmann co-lead the team.

Shook, Hardy & Bacon LLP‘s practice is well-equipped to assist well-known, sector-spanning clients on the array of patent portfolio management, analysis, strategy, procurement and prosecution matters. The team is co-led by Michael Gross, Trent Webb, and Cory Fisher, all of whom co-lead the team from the firm’s Kansas City hub. Elena McFarland is experienced assisting with patent prosecution cases in relation to the pharma, life sciences, and tech industries. Keith Bae is also highly regarded.